Pharmocokinetics of hexobarbital in man after intravenous infusion
- PMID: 1127574
- DOI: 10.1007/BF01066591
Pharmocokinetics of hexobarbital in man after intravenous infusion
Abstract
The plasma levels of hexobarbital in humans were determined during and after a 30-min or 60-min zero-order intravenous infusion. Hexobarbital kinetics could be described by conceiving the body to exhibit two compartments. The plasma concentrations were fitted to the postinfusion equation and the parameters intrinsic to the two-compartment open model were estimated. The elimination half-life varied considerably among the 14 individuals (160-441-min), which could mainly be explained by the greatly varying metabolic clearance of the compound (123-360 ml/min). The apparent volume of distribution per kilogram of body weight was relatively constant (1.10 plus or minus 0.12 liters/kg).
Similar articles
-
Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):219-27. doi: 10.1007/BF00614021. Eur J Clin Pharmacol. 1975. PMID: 1233266
-
Pharmacokinetics of hexobarbital in acute hepatitis and after apparent recovery.Clin Pharmacol Ther. 1975 Oct;18(4):433-40. doi: 10.1002/cpt1975184433. Clin Pharmacol Ther. 1975. PMID: 1164825
-
Apparent failure of the two-compartment open model in describing the pharmacokinetics of intravenously injected hexobarbital in mice.Arch Int Pharmacodyn Ther. 1971 Feb;189(2):388-9. Arch Int Pharmacodyn Ther. 1971. PMID: 5548781 No abstract available.
-
Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.Clin Pharmacol Ther. 1977 Apr;21(4):470-81. doi: 10.1002/cpt1977214470. Clin Pharmacol Ther. 1977. PMID: 849678
-
Metabolic and psychophysiologic studies of cannabidiol-hexobarbital interaction.Clin Pharmacol Ther. 1980 Jul;28(1):115-20. doi: 10.1038/clpt.1980.139. Clin Pharmacol Ther. 1980. PMID: 7389248
Cited by
-
Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):219-27. doi: 10.1007/BF00614021. Eur J Clin Pharmacol. 1975. PMID: 1233266
-
A linear recirculation model for drug disposition.J Pharmacokinet Biopharm. 1979 Feb;7(1):101-16. doi: 10.1007/BF01059445. J Pharmacokinet Biopharm. 1979. PMID: 458553
-
Compartment- and model-independent linear plateau principle of drugs during a constant-rate absorption or intravenous infusion.J Pharmacokinet Biopharm. 1980 Jun;8(3):311-8. doi: 10.1007/BF01059648. J Pharmacokinet Biopharm. 1980. PMID: 7420272
-
Pharmacokinetics of phenobarbital in childhood.Eur J Clin Pharmacol. 1977 Dec 2;12(4):305-10. doi: 10.1007/BF00607431. Eur J Clin Pharmacol. 1977. PMID: 590316
-
Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults.Eur J Clin Pharmacol. 1982;22(4):359-65. doi: 10.1007/BF00548406. Eur J Clin Pharmacol. 1982. PMID: 7106172